{"id":30511,"date":"2021-09-13T09:00:49","date_gmt":"2021-09-13T14:00:49","guid":{"rendered":"https:\/\/fshds.wpengine.com\/?p=30511"},"modified":"2021-09-09T13:48:15","modified_gmt":"2021-09-09T18:48:15","slug":"genetic-testing-for-fshd-in-asia","status":"publish","type":"post","link":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/","title":{"rendered":"Genetic testing for FSHD in Asia"},"content":{"rendered":"<p><em><strong>Article contributed by Pangenia.<\/strong><\/em><\/p>\n<h3><strong>About Pangenia Genomics<\/strong><\/h3>\n<p>Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia is to provide feasible, timely and accurate diagnostic and treatment options to patients afflicted by rare diseases and to offer guidance to their families.<\/p>\n<p>In 2019 we have established <a href=\"https:\/\/panrare.com\/en\/index\" target=\"_blank\" rel=\"noopener\">Pangenia Center of Excellence for Rare Diseases<\/a> (PanRARE). The Center comprises key opinion and treatment leaders in the field of orphan diseases. It is the first regional venue aimed at providing patients and clinicians with a comprehensive diagnostics and treatment options for muscular dystrophies including Facioscapulohumeral Muscular Dystrophy (FSHD). PanRARE connects patients, doctors, academia, key opinion leaders, drug discovery and development enterprises and patient advocacy groups that specialize in muscular dystrophies. We collaborate with industry that actively works on developing innovative diagnostics and therapeutics for FSHD. For example, partnerships with <a href=\"https:\/\/myocea.com\/index\" target=\"_blank\" rel=\"noopener\">Myocea, Inc<\/a>., and <a href=\"http:\/\/www.genomicvision.com\" target=\"_blank\" rel=\"noopener\">Genomic Vision<\/a>\u00a0provide synergistic expertise in phenotypic screening, identification of biomarkers and therapeutics development in FSHD.<\/p>\n<h3><strong>Molecular Testing of FSHD at PanRARE CoE<\/strong><\/h3>\n<p>We employ the Molecular Combing\u2122 platform to reliably diagnose FSHD1. This Genomic Morse Code technology is originally developed by Genomic Vision. The method uses specific fluorescent probes to hybridize with genomic DNA molecules (extracted from fresh blood samples) linearly stretched on coverslips (Figure 1). The fluorescent signals can then be visualized to distinguish the length (number of D4Z4 repeat units) and the type (haplotype A or B) of the D4Z4 loci (Figure 2).<\/p>\n<figure id=\"attachment_30513\" aria-describedby=\"caption-attachment-30513\" style=\"width: 1024px\" class=\"wp-caption alignright\"><a href=\"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design.png\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-30513 size-large\" src=\"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-1024x477.png\" alt=\"\" width=\"1024\" height=\"477\" srcset=\"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-1024x477.png 1024w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-300x140.png 300w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-768x358.png 768w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-1536x715.png 1536w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-1280x596.png 1280w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-260x121.png 260w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-644x300.png 644w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-200x93.png 200w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-564x263.png 564w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design-600x279.png 600w, https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/FSHD-Genomic-Morse-Code-GMC-Design.png 1606w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption id=\"caption-attachment-30513\" class=\"wp-caption-text\">Figure 1: FSHD Genomic Morse Code (GMC) Design<\/figcaption><\/figure>\n<figure id=\"attachment_30512\" aria-describedby=\"caption-attachment-30512\" style=\"width: 1024px\" class=\"wp-caption alignright\"><a href=\"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/Pangenia-Examples-of-hybridization-signals.png\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-30512 size-large\" src=\"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/Pangenia-Examples-of-hybridization-signals-1024x250.png\" alt=\"\" width=\"1024\" height=\"250\" \/><\/a><figcaption id=\"caption-attachment-30512\" class=\"wp-caption-text\">Figure 2: Examples of hybridization signals<\/figcaption><\/figure>\n<p>To date, we have provided expeditious and rapid services to FSHD patients from both Hong Kong and Mainland China. Our team at PanRARE CoE team is happy to assist you and your loved ones with diagnostic needs.<\/p>\n<h3><strong>\u0627\u062a\u0635\u0644 \u0628\u0646\u0627<\/strong><\/h3>\n<p><em>Prospective patients are to contact Pangenia Genomics for more information on the blood sample collection and processing<\/em>.<\/p>\n<p><strong>Pangenia Genomics (<a href=\"https:\/\/panrare.com\/en\/index\" target=\"_blank\" rel=\"noopener\">website<\/a>)<\/strong><br \/>\nUnit 1380, 13\/F, KITEC, 1 Trademart Drive, Kowloon Bay, Hong Kong<br \/>\n<strong>Phone:<\/strong>\u00a0<a href=\"tel:+85239896160\">(+852) 3989 6160 \u00a0<\/a><strong>Fax:<\/strong>\u00a0(+852) 2147 4138<br \/>\n<strong>Email:<\/strong>\u00a0<a href=\"mailto:info@panrare.com\">info@panrare.com<\/a><\/p>\n<p><strong>Monday &#8211; Saturday:<\/strong> 9:00am &#8211; 6:30pm, <strong>Sunday &amp; Public holidays:<\/strong>\u00a0Closed<\/p>","protected":false},"excerpt":{"rendered":"<p>Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":30512,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[252,42],"tags":[],"class_list":["post-30511","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-and-medicine","category-living-with-fshd"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"jkinoshita\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"ar_AR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"FSHD Society - Empowering FSHD Patients, Accelerating FSHD Progress\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Genetic testing for FSHD in Asia - FSHD Society\" \/>\n\t\t<meta property=\"og:description\" content=\"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2021-09-13T14:00:49+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2021-09-09T18:48:15+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FSHDSociety\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@FSHDSociety\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Genetic testing for FSHD in Asia - FSHD Society\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@FSHDSociety\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#blogposting\",\"name\":\"Genetic testing for FSHD in Asia - FSHD Society\",\"headline\":\"Genetic testing for FSHD in Asia\",\"author\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/author\\\/jkinoshita\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.fshdsociety.org\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Pangenia-Examples-of-hybridization-signals-e1631212768875.png\",\"width\":512,\"height\":277},\"datePublished\":\"2021-09-13T09:00:49-05:00\",\"dateModified\":\"2021-09-09T13:48:15-05:00\",\"inLanguage\":\"ar\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#webpage\"},\"articleSection\":\"Health and Medicine, Living with FSHD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/#listItem\",\"name\":\"Living with FSHD\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/#listItem\",\"position\":2,\"name\":\"Living with FSHD\",\"item\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/health-and-medicine\\\/#listItem\",\"name\":\"Health and Medicine\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/health-and-medicine\\\/#listItem\",\"position\":3,\"name\":\"Health and Medicine\",\"item\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/health-and-medicine\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#listItem\",\"name\":\"Genetic testing for FSHD in Asia\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/#listItem\",\"name\":\"Living with FSHD\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#listItem\",\"position\":4,\"name\":\"Genetic testing for FSHD in Asia\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/category\\\/living-with-fshd\\\/health-and-medicine\\\/#listItem\",\"name\":\"Health and Medicine\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/#organization\",\"name\":\"FSHD Society\",\"description\":\"Empowering FSHD Patients, Accelerating FSHD Progress\",\"url\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/\",\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FSHDSociety\\\/\",\"https:\\\/\\\/twitter.com\\\/FSHDSociety\",\"https:\\\/\\\/www.instagram.com\\\/fshdsociety\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/fshd-society\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/author\\\/jkinoshita\\\/#author\",\"url\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/author\\\/jkinoshita\\\/\",\"name\":\"jkinoshita\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/621e672c0a41d7dbeb72354caf1ec333ade5344df6b3ba3d6917f43947ca7d63?s=128&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"jkinoshita\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#webpage\",\"url\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/\",\"name\":\"Genetic testing for FSHD in Asia - FSHD Society\",\"description\":\"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia\",\"inLanguage\":\"ar\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/author\\\/jkinoshita\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/author\\\/jkinoshita\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.fshdsociety.org\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Pangenia-Examples-of-hybridization-signals-e1631212768875.png\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#mainImage\",\"width\":512,\"height\":277},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/2021\\\/09\\\/13\\\/genetic-testing-for-fshd-in-asia\\\/#mainImage\"},\"datePublished\":\"2021-09-13T09:00:49-05:00\",\"dateModified\":\"2021-09-09T13:48:15-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/#website\",\"url\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/\",\"name\":\"FSHD Society\",\"description\":\"Empowering FSHD Patients, Accelerating FSHD Progress\",\"inLanguage\":\"ar\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.fshdsociety.org\\\/ar\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Genetic testing for FSHD in Asia - FSHD Society","description":"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia","canonical_url":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#blogposting","name":"Genetic testing for FSHD in Asia - FSHD Society","headline":"Genetic testing for FSHD in Asia","author":{"@id":"https:\/\/www.fshdsociety.org\/ar\/author\/jkinoshita\/#author"},"publisher":{"@id":"https:\/\/www.fshdsociety.org\/ar\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/Pangenia-Examples-of-hybridization-signals-e1631212768875.png","width":512,"height":277},"datePublished":"2021-09-13T09:00:49-05:00","dateModified":"2021-09-09T13:48:15-05:00","inLanguage":"ar","mainEntityOfPage":{"@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#webpage"},"isPartOf":{"@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#webpage"},"articleSection":"Health and Medicine, Living with FSHD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar#listItem","position":1,"name":"Home","item":"https:\/\/www.fshdsociety.org\/ar","nextItem":{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/#listItem","name":"Living with FSHD"}},{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/#listItem","position":2,"name":"Living with FSHD","item":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/health-and-medicine\/#listItem","name":"Health and Medicine"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/health-and-medicine\/#listItem","position":3,"name":"Health and Medicine","item":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/health-and-medicine\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#listItem","name":"Genetic testing for FSHD in Asia"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/#listItem","name":"Living with FSHD"}},{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#listItem","position":4,"name":"Genetic testing for FSHD in Asia","previousItem":{"@type":"ListItem","@id":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/health-and-medicine\/#listItem","name":"Health and Medicine"}}]},{"@type":"Organization","@id":"https:\/\/www.fshdsociety.org\/ar\/#organization","name":"FSHD Society","description":"Empowering FSHD Patients, Accelerating FSHD Progress","url":"https:\/\/www.fshdsociety.org\/ar\/","sameAs":["https:\/\/www.facebook.com\/FSHDSociety\/","https:\/\/twitter.com\/FSHDSociety","https:\/\/www.instagram.com\/fshdsociety\/","https:\/\/www.linkedin.com\/company\/fshd-society"]},{"@type":"Person","@id":"https:\/\/www.fshdsociety.org\/ar\/author\/jkinoshita\/#author","url":"https:\/\/www.fshdsociety.org\/ar\/author\/jkinoshita\/","name":"jkinoshita","image":{"@type":"ImageObject","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/621e672c0a41d7dbeb72354caf1ec333ade5344df6b3ba3d6917f43947ca7d63?s=128&d=mm&r=g","width":96,"height":96,"caption":"jkinoshita"}},{"@type":"WebPage","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#webpage","url":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/","name":"Genetic testing for FSHD in Asia - FSHD Society","description":"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia","inLanguage":"ar","isPartOf":{"@id":"https:\/\/www.fshdsociety.org\/ar\/#website"},"breadcrumb":{"@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#breadcrumblist"},"author":{"@id":"https:\/\/www.fshdsociety.org\/ar\/author\/jkinoshita\/#author"},"creator":{"@id":"https:\/\/www.fshdsociety.org\/ar\/author\/jkinoshita\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.fshdsociety.org\/wp-content\/uploads\/2021\/09\/Pangenia-Examples-of-hybridization-signals-e1631212768875.png","@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#mainImage","width":512,"height":277},"primaryImageOfPage":{"@id":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/#mainImage"},"datePublished":"2021-09-13T09:00:49-05:00","dateModified":"2021-09-09T13:48:15-05:00"},{"@type":"WebSite","@id":"https:\/\/www.fshdsociety.org\/ar\/#website","url":"https:\/\/www.fshdsociety.org\/ar\/","name":"FSHD Society","description":"Empowering FSHD Patients, Accelerating FSHD Progress","inLanguage":"ar","publisher":{"@id":"https:\/\/www.fshdsociety.org\/ar\/#organization"}}]},"og:locale":"ar_AR","og:site_name":"FSHD Society - Empowering FSHD Patients, Accelerating FSHD Progress","og:type":"article","og:title":"Genetic testing for FSHD in Asia - FSHD Society","og:description":"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia","og:url":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/","article:published_time":"2021-09-13T14:00:49+00:00","article:modified_time":"2021-09-09T18:48:15+00:00","article:publisher":"https:\/\/www.facebook.com\/FSHDSociety\/","twitter:card":"summary_large_image","twitter:site":"@FSHDSociety","twitter:title":"Genetic testing for FSHD in Asia - FSHD Society","twitter:description":"Article contributed by Pangenia. About Pangenia Genomics Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia","twitter:creator":"@FSHDSociety"},"aioseo_meta_data":{"post_id":"30511","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-03-26 21:25:52","updated":"2025-06-04 09:06:43","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.fshdsociety.org\/ar\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/\" title=\"Living with FSHD\">Living with FSHD<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/health-and-medicine\/\" title=\"Health and Medicine\">Health and Medicine<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tGenetic testing for FSHD in Asia\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.fshdsociety.org\/ar"},{"label":"Living with FSHD","link":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/"},{"label":"Health and Medicine","link":"https:\/\/www.fshdsociety.org\/ar\/category\/living-with-fshd\/health-and-medicine\/"},{"label":"Genetic testing for FSHD in Asia","link":"https:\/\/www.fshdsociety.org\/ar\/2021\/09\/13\/genetic-testing-for-fshd-in-asia\/"}],"_links":{"self":[{"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/posts\/30511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/comments?post=30511"}],"version-history":[{"count":0,"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/posts\/30511\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/media\/30512"}],"wp:attachment":[{"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/media?parent=30511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/categories?post=30511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fshdsociety.org\/ar\/wp-json\/wp\/v2\/tags?post=30511"}],"curies":[{"name":"\u062f\u0628\u0644\u064a\u0648 \u0628\u064a","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}